The growing prevalence of diseases, especially among geriatric population combined with increasing awareness among the present population regarding better accessibility of technologically innovative devices such as human patient monitoring devices is boosting the growth of the North America patient (human) monitoring devices market. Incorporating patient monitoring in chronic disease management can significantly improve a person's quality of life as a monitoring device is able to inform patients about critical deterioration of their health or when they need to apply for emergency help as soon as possible.
The North America patient (human) monitoring devices market accounted for USD 1,881.8 Million in 2013. Factors such as multi-functionality, reduced logistical expenses as well as early preventive diagnosis of diseases is estimated to benefit the expansion of the North America patient (human) monitoring devices market with a CAGR of 5.6% over the forecast period 2018-2024. Further, the market size of the North America patient (human) monitoring devices market is estimated to reach USD 3,329.9 Million in 2024.
In terms of market segmentation, the North America patient (human) monitoring devices market is divided by technology into wired and wireless, out of which, the wireless technology accounted for the market share of around 60% in 2013 and with increasing demand for wireless devices due to their better portability and ease of handling combined with growing dependency on wireless devices as compared to the wired devices, the wireless segment is estimated to have a significant market share in upcoming years.
The North America patient (human) monitoring devices market is also segmented into product type and end-user, out of which, the product type is further segmented into vital sign monitoring, infusion pumps, cardiac monitoring, respiratory monitoring devices, hematological monitoring devices, anesthesia systems monitoring devices, renal function monitoring devices, telemetry devices, multi-parameter monitors and other monitoring devices. Among these segments, the vital sign monitoring and cardiac monitoring segment are the highest revenue generating segments in the market of North America patient (human) monitoring devices.
The Report titled “North America Patient (Human) Monitoring Devices Market Outlook: Industry Analysis & Opportunity Evaluation 2013-2024” also includes some prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter’s five force model.
This report also studies existing competitive scenario of some of the key players of the North America patient (human) monitoring devices market which includes profiling of BioTelemetry Inc., Medtronic, Honeywell HomMed, Boston Scientific Corporation, Applied Cardiac Systems Inc., GE Healthcare, Philips Healthcare, Roche Diagnostics, Abbott Laboratories and Paragon Medical Supply Inc.
The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “North America Patient (Human) Monitoring Devices Market Outlook 2024”, analyses the overall patient (human) monitoring devices industry in North America to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the North America patient (human) monitoring devices market in the near future. To know more about this research
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
77 Water Street 7th Floor,New York, New York, 10005
+1 646 586 9123
+1 437 889 3230
UK Office (London)
+44 203 608 5919
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
Phone : +1 437 889 3230
Phone : +44 203 608 5919
Copyright © 2018 Research Nester. All rights reserved